CD47 and atherosclerosis: Given that the expression of the CD47 protein is increased in many diseases, e.g., in atherosclerosis, Kojima et al. [112] demonstrated that the blocking antibody therapy to the CD47 protein restored the phagocytic activity of macrophages and reduced the severity of atherosclerosis in experimental mouse models.